Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Allergan enters into a global agreement with AstraZeneca to develop and commercialize ATM-AVI

Feb. 1, 2016

GenArraytion introduces first commercially available Zika virus test

Feb. 1, 2016

Shionogi and Nissan Chemical enter strategic antifungal research collaboration agreement

Feb. 1, 2016

RSV Corporation ends RSV collaboration with Mymetics

Feb. 1, 2016

FDA approves Merck & Co.'s Zepatier for HCV infection

Jan. 29, 2016

Giant multivalent glycofullerenes inhibit cell infection by Ebola virus

Jan. 29, 2016

Genticel reports phase II trial results for ProCervix

Jan. 29, 2016

Synthetic lethality approach used to identify antibacterial compounds

Jan. 29, 2016

Replikins selects peptide Zika virus vaccine for preclinical efficacy studies

Jan. 28, 2016

FDA accepts BLA for bezlotoxumab

Jan. 28, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...